The Coriell Institute for Medical Research Inc, with an EIN of 21-0672684, is dedicated to advancing the field of biology through the generation of world-class biomaterials and groundbreaking research. Operating with a budget of $24.2 million and generating total revenue of $32.1 million in the 2024 fiscal year, the organization is supported by multiple significant funders, none of which contribute 50% or more of its revenue. More information about its initiatives can be found on its website at www.coriell.org.